Mixtures of cannabinoid compounds, and production and use thereof

US10913729B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10913729-B2
Application numberUS-201816181503-A
CountryUS
Kind codeB2
Filing dateNov 6, 2018
Priority dateFeb 26, 2015
Publication dateFeb 9, 2021
Grant dateFeb 9, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Described are also corresponding pharmaceutical formulations, cosmetic preparations and preparations for pleasure and/or nutrition, suitable for consumption, as well as methods for producing CBDV and THCV.

First claim

Opening claim text (preview).

The invention claimed is: 1. A mixture comprising one or more compounds of formula (A) and/or salts thereof wherein R 1 is a C 1 -C 15 aliphatic substituent optionally substituted with one or more hydroxyl groups, wherein the aliphatic substituent is saturated or unsaturated, branched or linear, and acyclic or cyclic, provided that if R 1 is an aliphatic substituent with no hydroxyl groups, the one or more compounds of formula (A) is/are selected from cyclohexylcannabidivarinolat, hexylcannabidivarinolat, salts thereof, and a mixture thereof. 2. The mixture according to claim 1 , wherein the aliphatic substituent is saturated and/or linear. 3. The mixture according to claim 1 comprising a compound of formula (A-I) wherein, each R 1 is independently H, a C 1 -C 2 alkyl, or OH, R 2 is H or OH, n is an integer from 2 to 10, provided that at least one of R 1 or R 2 is OH. 4. The mixture according to claim 1 comprising a compound of formula (A-II) wherein, each R 1 is independently H, a C 1 -C 2 alkyl, or OH, R 2 is H or OH, n is an integer from 2 to 10, provided that at least one of R 1 or R 2 is OH. 5. A mixture according to claim 1 comprising a compound of formula (A-III) wherein, each R 1 is independently H, a C 1 -C 2 alkyl, or OH, R 2 is H or OH, n is an integer from 2 to 10, provided that least one of R 1 or R 2 is OH. 6. The mixture according to claim 1 comprising a compound of formula (A-IV) wherein each R 1 is independently H, a C 1 -C 2 alkyl, or OH, and n is an integer from 2 to 10. 7. A mixture according to claim 3 , wherein each R 1 of the compound of formula (A-I) is independently H or OH. 8. A mixture according to claim 4 , wherein each R 1 of the compound of formula (A-II) is independently H or OH. 9. A mixture according to claim 5 , wherein each R 1 of the compound of formula (A-III) is independently H or OH. 10. A mixture according to claim 6 , wherein each R 1 of the compound of formula (A-IV) is independently H or OH. 11. A mixture according to claim 1 , wherein the compound of the formula (A) is a compound of formula (IV): 12. A method for producing a mixture according to claim 1 comprising: reacting an ester of the formula (IX) wherein Y is an organic substituent, with an alcohol of the formula HO—X, wherein X is a C 1 -C 15 aliphatic substituent optionally substituted with one or more hydroxyl groups, wherein the aliphatic substituent is saturated or unsaturated, branched or linear, and acyclic or cyclic, provided that if X is an aliphatic substituent with no hydroxyl groups, the alcohol of formula HO-X is selected from cyclohexanol and hexanol; wherein Y is different from X and selected such that the alcohol of formula HO—Y formed during the reaction boils at 1013 hPa at a lower temperature than the alcohol of formula HO—X. 13. A pharmaceutical or cosmetic formulation comprising a mixture according to claim 1 . 14. A formulation suitable for consumption comprising a mixture according to claim 1 . 15. The mixture according to claim 1 comprising a compound of formula (V) (cannabidivarin, CBDV): and/or a compound of formula (III) ((−)-trans-methylcannabidivarinolat): wherein if the mixture comprises a compound of formula (V), a molar ratio of a total amount of the one or more compounds of formula (A) and/or salts thereof to a total amount of the compound of formula (V) is greater than 1:1, and if the mixture comprises a compound of formula (III), a molar ratio of a total amount of the one or more compounds of formula (A) and/or salts thereof to a total amount of the compound of formula (III) is greater than 1:1.

Assignees

Inventors

Classifications

  • o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol · CPC title

  • of polycyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of six-membered aromatic rings · CPC title

  • A61K31/235Primary

    having an aromatic ring attached to a carboxyl group · CPC title

  • by reacting an ester group with a hydroxy group · CPC title

  • Antihypertensives · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10913729B2 cover?
Described are also corresponding pharmaceutical formulations, cosmetic preparations and preparations for pleasure and/or nutrition, suitable for consumption, as well as methods for producing CBDV and THCV.
Who is the assignee on this patent?
Symrise Ag
What technology area does this patent fall under?
Primary CPC classification A61K31/235. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Feb 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).